Several groups have found that E-cadherin status of breast carcinomas showed weak or no correlation with vascular invasion [34], nodal status [41], [42], the presence of metastases [34], [41], and disease recurrence or survival [34], [41], [42]. Here, CDH1 is linked to breast carcinoma.